Marcus C. Rosenhagen

863 total citations
15 papers, 586 citations indexed

About

Marcus C. Rosenhagen is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Marcus C. Rosenhagen has authored 15 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Marcus C. Rosenhagen's work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Estrogen and related hormone effects (3 papers). Marcus C. Rosenhagen is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Estrogen and related hormone effects (3 papers). Marcus C. Rosenhagen collaborates with scholars based in Germany, United States and Hungary. Marcus C. Rosenhagen's co-authors include Manfred Uhr, Theo Rein, Bertram Müller‐Myhsok, Tatjana Dose, Martin Kohli, Susanne Lucae, Michael Specht, Elisabeth B. Binder, Marcus Ising and Martin Ebinger and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Molecular Pharmacology.

In The Last Decade

Marcus C. Rosenhagen

15 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus C. Rosenhagen Germany 10 195 122 118 94 88 15 586
Trevor I. Prior Canada 11 206 1.1× 54 0.4× 62 0.5× 90 1.0× 236 2.7× 14 732
Hsiang‐Wei Kuo Taiwan 14 128 0.7× 60 0.5× 78 0.7× 54 0.6× 62 0.7× 29 500
Angela C. Doran United States 14 213 1.1× 213 1.7× 127 1.1× 68 0.7× 77 0.9× 25 642
Inez C. J. van der Sandt Netherlands 9 138 0.7× 385 3.2× 235 2.0× 68 0.7× 55 0.6× 9 756
Susan Nielsen United States 10 247 1.3× 49 0.4× 30 0.3× 168 1.8× 83 0.9× 27 754
Jukka Tenhunen Finland 14 409 2.1× 55 0.5× 45 0.4× 57 0.6× 144 1.6× 18 1.0k
Wendy Luo United States 16 262 1.3× 73 0.6× 110 0.9× 27 0.3× 72 0.8× 34 823
M. Bagli Germany 11 164 0.8× 52 0.4× 21 0.2× 53 0.6× 105 1.2× 19 480
Haichuan Duan United States 15 257 1.3× 239 2.0× 146 1.2× 43 0.5× 30 0.3× 20 633
Julie Cianfrogna United States 7 168 0.9× 149 1.2× 84 0.7× 46 0.5× 46 0.5× 7 463

Countries citing papers authored by Marcus C. Rosenhagen

Since Specialization
Citations

This map shows the geographic impact of Marcus C. Rosenhagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus C. Rosenhagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus C. Rosenhagen more than expected).

Fields of papers citing papers by Marcus C. Rosenhagen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus C. Rosenhagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus C. Rosenhagen. The network helps show where Marcus C. Rosenhagen may publish in the future.

Co-authorship network of co-authors of Marcus C. Rosenhagen

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus C. Rosenhagen. A scholar is included among the top collaborators of Marcus C. Rosenhagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus C. Rosenhagen. Marcus C. Rosenhagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rosenhagen, Marcus C. & Manfred Uhr. (2011). The Clinical Impact of ABCB1 Polymorphisms on the Treatment of Psychiatric Diseases. Current Pharmaceutical Design. 17(26). 2843–2851. 13 indexed citations
2.
Dresler, Martin, Lisa Genzel, Michael Kluge, et al.. (2010). Off-line memory consolidation impairments in multiple sclerosis patients receiving high-dose corticosteroid treatment mirror consolidation impairments in depression. Psychoneuroendocrinology. 35(8). 1194–1202. 24 indexed citations
3.
Rosenhagen, Marcus C., et al.. (2009). A Risk Profile for Invasive Aspergillosis in Liver Transplant Recipients. Infection. 37(4). 313–319. 45 indexed citations
4.
Uhr, Manfred, Alina Tontsch, Christian Namendorf, et al.. (2008). Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression. Neuron. 57(2). 203–209. 265 indexed citations
5.
Behl, Christian, et al.. (2007). P-Glycoprotein has negligible effects on estradiol and testosterone in mice. Neuroscience Letters. 427(1). 6–9. 3 indexed citations
6.
Uhr, Manfred, et al.. (2005). The anti-Parkinson drug budipine is exported actively out of the brain by P-glycoprotein in mice. Neuroscience Letters. 383(1-2). 73–76. 15 indexed citations
7.
Maccarrone, Giuseppina, Dale Milfay, Isabel Birg, et al.. (2004). Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry. Electrophoresis. 25(14). 2402–2412. 71 indexed citations
8.
Maccarrone, Giuseppina, Isabel Birg, Marcus C. Rosenhagen, et al.. (2004). In-depth analysis of the human CSF proteome using protein prefractionation. Clinical Proteomics. 1(3-4). 333–364. 11 indexed citations
9.
Rosenhagen, Marcus C., et al.. (2004). Analysis of cerebrospinal fluid of depressed patients. Pharmacopsychiatry. 36(5). 1 indexed citations
10.
Maccarrone, Giuseppina, Isabel Birg, Marcus C. Rosenhagen, et al.. (2004). In-depth analyis of the human CSF proteome using protein prefractionation. Max Planck Institute for Plasma Physics. 1. 333–364. 1 indexed citations
11.
Rosenhagen, Marcus C., Csaba Sőti, Ulrike Schmidt, et al.. (2003). The Heat Shock Protein 90-Targeting Drug Cisplatin Selectively Inhibits Steroid Receptor Activation. Molecular Endocrinology. 17(10). 1991–2001. 43 indexed citations
12.
Schmidt, Ulrike, Gabriela M. Wochnik, Marcus C. Rosenhagen, et al.. (2003). Essential Role of the Unusual DNA-binding Motif of BAG-1 for Inhibition of the Glucocorticoid Receptor. Journal of Biological Chemistry. 278(7). 4926–4931. 47 indexed citations
13.
Rosenhagen, Marcus C., Jason C. Young, Gabriela M. Wochnik, et al.. (2001). Synergistic Inhibition of the Glucocorticoid Receptor by Radicicol and Benzoquinone Ansamycins. Biological Chemistry. 382(3). 499–504. 8 indexed citations
14.
Rosenhagen, Marcus C., et al.. (2000). Rifampicin Is Not an Activator of Glucocorticoid Receptor. Molecular Pharmacology. 57(4). 732–737. 2 indexed citations
15.
Rosenhagen, Marcus C., et al.. (2000). Rifampicin Is Not an Activator of Glucocorticoid Receptor. Molecular Pharmacology. 57(4). 732–737. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026